Home Latest News WHO Calls for Accelerated and Focused Effort to Reach Every Child With Life-Saving Vaccines in South-East Asia Region
Latest NewsWHO

WHO Calls for Accelerated and Focused Effort to Reach Every Child With Life-Saving Vaccines in South-East Asia Region

Share
WHO
Share

The World Health Organization today called on countries in South-East Asia Region to further strengthen efforts at all levels, with tailored approaches at sub-national levels, to identify and immunize unvaccinated and under vaccinated children. As per the latest global data, in 2023 nearly 3.4 million children in the Region did not get all vaccines being offered under the childhood immunization programme with 2.7 million among them not getting any vaccines, leaving them vulnerable to life threatening diseases.

“The increasing numbers of unvaccinated and under vaccinated children calls for urgent and accelerated action. We need to identify where and why these children are missed and prioritize reaching them at the earliest. No child should fall sick or die of any vaccine preventable disease when safe and effective vaccines exist to protect them against these deadly diseases,” said Ms Saima Wazed, Regional Director WHO South-East Asia.

The Region is off track to achieve 2030 immunization agenda and the regional vaccine action plan to achieve over 90% coverage with three doses of diphtheria, pertussis, and tetanus (DTP3) vaccines in all countries.

The WHO and UNICEF joint immunization data for 2023 shows DTP1 coverage in the Region at 92%, below the pre-pandemic 94% in 2019 and DTP3 coverage, indicator of full immunization, at 90%, less than pre-pandemic 91% in 2019. Children receiving first dose of measles vaccine – typically at 9 or 12 months – declined to 91% in 2023 from 94% in 2019, while coverage with the second dose of measles vaccine administered to children between 18 months and five years old remained relatively constant at 85%.

“The focus must be on tailored approaches, identified in consultation with the affected communities – local solutions to local issues. No matter how challenging or remote the setting is, we will need to find new ways to reach the children most at risk of life-threatening diseases,” Ms Wazed said.

In recent years, the Region has had many public health advances facilitated by vaccination – such as elimination of polio and maternal and neonatal tetanus, while some countries have eliminated measles, rubella and controlled hepatitis B among children. Lessons from these achievements, specially from the last mile, should be applied to reach the unvaccinated and under vaccinated children.

Populations and areas with missed and under vaccinated children must be identified and prioritized for strategic interventions to implement high-quality vaccination campaigns and sessions. There is also a need for stronger partner coordination and engagement with communities for enhancing vaccination coverage.

Monitoring and accountability must be enhanced at all levels for timely identification and action to address issues and challenges.

To restore and enhance routine immunization coverage to and beyond pre-pandemic level, countries have been making significant efforts. In 2023, India, Indonesia, Myanmar, Nepal, Thailand and Timor-Leste conducted multiple national, subnational, and catch-up immunization campaigns with measles and rubella, polio, Japanese Encephalitis and other vaccines given under childhood immunization programs. Countries increased age limit for vaccination to up to five years in these catch campaigns to protect children who missed vaccination during COVID-19 pandemic. Over 25 million doses of vaccines were administered in catch-up campaigns in 2022-2023

“WHO remains committed to supporting countries in their efforts to increase immunization coverage to ensure every person has access to vaccines for their well-being and health,” the Regional Director said.

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss

Air Pollution
Health News

Delhi Chokes Under Toxic Air: Schools Shut, Offices Go Work From Home — How to Stay Safe

New Delhi, 23 December, 2025: Delhi once again finds itself gasping for breath as air pollution levels surge to hazardous levels, pushing authorities...

Colorectal cancer
Latest News

Cervical Cancer Awareness Month 2026: Screening Tips Every Woman Should Know

Cervical cancer is one of the most preventable forms of cancer, yet it remains a leading cause of cancer-related deaths among women globally....

Bird Flu
Latest News

Bird Flu Alert: How to Protect Yourself Without Panicking

Bird flu, also known as avian influenza, is a viral infection primarily affecting birds but capable of infecting humans in rare cases. The...

Latest News

Why Walking 30 Minutes a Day Can Add Years to Your Life

Walking for just 30 minutes a day is one of the simplest yet most effective ways to improve overall health, enhance longevity, and...

Latest News

5 Common Foods That Are Slowly Damaging Your Liver

The liver is one of the most vital organs in the body, responsible for detoxification, metabolizing nutrients, and regulating essential biochemical processes, and...

Section title

Related Articles
Cancer
Latest News

Immunotherapy vs Chemotherapy: Which Cancer Treatment Works Better?

Cancer treatment has evolved rapidly over the past few decades, offering patients...

The Nipah virus is considered one of the deadliest zoonotic infections globally, not because it spreads rapidly like influenza or COVID-19, but because of its extremely high fatality rate, rapid progression, and severe brain involvement. Medical experts warn that once symptoms escalate, the disease can turn fatal within days. According to available data, the case fatality rate of Nipah virus ranges between 50 and 75 per cent, placing it among the most lethal viral infections known to humans. In this explainer, Dr Dip Narayan Mukherjee, Consultant – Microbiology and Infectious Diseases, CK Birla Hospitals, CMRI, sheds light on why the virus is so dangerous and difficult to control. Why Is the Nipah Virus So Deadly? According to Dr Mukherjee, Nipah’s lethality lies in a combination of delayed symptom recognition, aggressive disease progression, and early involvement of the brain. “Nipah virus often begins with very non-specific symptoms, which makes early detection difficult. By the time it is clinically suspected, the virus may have already affected the brain,” he explains. Early Symptoms Often Go Unnoticed One of the biggest challenges in controlling Nipah virus is that its initial symptoms closely resemble common viral illnesses, leading to delays in diagnosis and isolation. Early symptoms include: Fever Headache Cough Muscle pain General weakness “These symptoms are easily mistaken for flu, viral fever, or respiratory infections,” says Dr Mukherjee. “This delay gives the virus time to progress silently.” Severe Brain Infection Drives High Mortality The most dangerous aspect of Nipah virus infection is its neurological involvement. The virus frequently causes encephalitis, or inflammation of the brain, which significantly increases the risk of death. Neurological symptoms may include: Seizures Confusion and altered consciousness Extreme drowsiness Coma “Once the central nervous system is involved, the disease becomes very difficult to manage,” Dr Mukherjee notes. “At this stage, treatment is largely supportive because there is no specific antiviral therapy available.” This lack of targeted treatment options makes early detection critical. Human-to-Human Transmission Raises Risk While Nipah virus is primarily transmitted from fruit bats, it can also spread from person to person, particularly in healthcare settings. Dr Mukherjee points out that: Caregivers and healthcare workers are at higher risk Exposure to high viral loads can worsen outcomes Inadequate infection control increases transmission risk “Strict adherence to infection control practices is essential. Even a small lapse can result in secondary infections,” he says. Zoonotic Nature Makes Exposure Hard to Predict Nipah virus is transmitted from fruit bats, either directly or through intermediate hosts such as pigs. This zoonotic pattern makes outbreaks unpredictable, especially in regions where humans, animals, and wildlife interact closely. Adding to the challenge: There is no approved vaccine Treatment options remain limited Isolation protocols must be strictly enforced What Can Reduce Nipah Fatalities? According to experts, early action remains the most effective defence against Nipah virus. Key measures include: Early isolation of suspected cases Strict use of personal protective equipment (PPE) Rapid escalation and referral to specialised centres Strong hospital infection control protocols “The earlier the virus is identified and contained, the better the chances of preventing severe disease and fatalities,” Dr Mukherjee emphasises. The Bottom Line Nipah virus continues to be a serious public health threat because of its high fatality rate, neurological complications, and lack of targeted treatment. Its ability to masquerade as a mild illness in the early stages makes vigilance crucial. Health experts stress that awareness, early suspicion, and strict infection control are currently the most powerful tools to reduce deaths linked to this deadly virus. As Dr Mukherjee concludes, “With Nipah, time is the most critical factor. Early recognition can save lives.”
Latest News

Why Nipah Virus Has a High Fatality Rate: Factors Affecting Disease Severity

The Nipah virus is widely regarded as one of the deadliest zoonotic...

Latest News

Stroke Risk in India: Symptoms and Urgent Action Steps

Stroke is a leading cause of death and disability in India, yet...

Latest News

Silent Struggle: Over 15 Million Indians Live with Epilepsy, Experts Stress Early Diagnosis and Care

Epilepsy, a neurological disorder that causes recurrent seizures, affects more than 15...

×